ZNF395 and benign neoplasm: Figure 3 shows the relative expression level of LOXL2 and ZNF395. LOXL2 showed increased expression in MPNST1, -7 and -9x, whereas ZNF395 showed approximately similar expression levels in the MPNSTs and the benign tumors.